Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors.

Aslan, Nevin Alayvaz; Hincal, Hande Ogul; Elver, Özde; Erol, Veysel; Güler, Nil

Aslan, Nevin Alayvaz; Hincal, Hande Ogul; Elver, Özde; Erol, Veysel; Güler, Nil.

Affiliation

Aslan NA; Faculty of Medicine, Hematology Department, 52990Pamukkale University, Denizli, Turkey.
Hincal HO; Faculty of Medicine, Hematology Department, 52990Pamukkale University, Denizli, Turkey.
Elver Ö; Faculty of Medicine, Hematology Department, 52990Pamukkale University, Denizli, Turkey.
Erol V; Faculty of Medicine, Hematology Department, 52990Pamukkale University, Denizli, Turkey.
Güler N; Faculty of Medicine, Hematology Department, 52990Pamukkale University, Denizli, Turkey.

J Oncol Pharm Pract ; 29(2): 511-516, 2023 Mar.

Article de En | MEDLINE | ID: mdl-35821583

Sujet(s)
Mots clés

Bosutinib, pleural effusion, cross-intolerance, chronic myeloid leukemia.

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Épanchement pleural / Leucémie myéloïde chronique BCR-ABL positive Limites: Humans / Male / Middle aged Langue: En Journal: J Oncol Pharm Pract Sujet du journal: FARMACIA Année: 2023 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google